Board's Determination Pursuant to Section 303A.07(a) of NYSE Listed Company Manual

Dr. Enrique Arzac, one of the Fund's directors, serves on the Fund's Audit Committee, and also serves on the audit committees of three other public companies. This service was disclosed to the Board of Directors of the Fund and, as required by Section 303A.07(a) of the NYSE Listed Company Manual, the Board formally determined that such simultaneous service would not impair Dr. Arzac’s ability to effectively serve on the Fund's Audit Committee.